Trial: 201910170

A Phase 1b, Master Protocol Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 510 in Subjects with Advanced Solid Tumors With KRAS p.G12C Mutation

Phase

I

Principal Investigator

Govindan, Ramaswamy

Disease Site

Breast; Esophagus; Lung; Lung Cancer – Non-small Cell; Melanoma, Skin; Sarcoma; Urinary Bladder

Learn more about this study at: clinicaltrials.gov